TLSA — Tiziana Life Sciences Share News
0.000.00%
- $115.83m
- $113.58m
U.S. STOCKS ON THE MOVE-Icosavax, MEI Pharma, Clever Leaves
Tiziana gains on starting human trial for Crohn's disease oral therapy
Brief: Tiziana Announces Initiation Of Phase 1B Clinical Trial In Crohn's Disease Patients To Evaluate Oral Capsules Of Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody
U.S. STOCKS ON THE MOVE-Halliburton, Couchbase, Newmont, Wingstop, Chevron
U.S. STOCKS ON THE MOVE-Chevron Corp, Goldman Sachs, Inari Medical
U.S. STOCKS ON THE MOVE-Asana, Build-A-Bear, Pilgrim's Pride
Tiziana jumps as intranasal spray well-tolerated in multiple sclerosis patient
Brief: Tiziana Announces Positive Clinical Data From A Secondary Progressive Multiple Sclerosis Patient Treated For Six Months With Intranasally Administered Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody
Brief: Tiziana Announces Submission Of Amendment To Investigational New Drug Application To Advance Oral Foralumab
Brief: Tiziana Life Sciences Announces Death Of Director
RCS - Tiziana Life Science - Tiziana Life Sciences Announces Death of Director
RCS - Tiziana Life Science - TLSA Enrolls Second Patient in Ongoing SPMS Trial
RCS - Tiziana Life Science - Information Regarding Migration of UK Shares
US STOCKS-Stocks rebound in late-day rally on Wall Street
Brief: Tiziana Life Sciences PLC Files For Mixed Shelf Of Upto $250 Million - SEC Filing
Tiziana Life Sciences: Rises on plans to list asset as separate company
U.S. STOCKS ON THE MOVE-MICT, Seanergy Maritime, Kohl's Corp
U.S. STOCKS ON THE MOVE-MICT, Seanergy Maritime, iMedia Brands
U.S. STOCKS ON THE MOVE-Seanergy Maritime, Tesla, iMedia Brands